Lovell Stephanie 4
4 · Cyclerion Therapeutics, Inc. · Filed Jun 28, 2021
Insider Transaction Report
Form 4
Lovell Stephanie
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24+10,000→ 10,000 totalExercise: $3.97Exp: 2031-06-24→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.